Empowering Patients
Improving Outcomes

We strive to improve the quality of life for people who suffer from depression, mania and anxiety.  By providing a practical, science-based tool for navigating shifting emotions, we help empower people to gain greater control over their lives.

The KIOS Team

The KIOS team is a dynamic mix of individuals with diverse skills. We share core values including a commitment to scientific rigor, improving public health, passionate customer support, mutual respect and ethical conduct.

KIOS would not exist without the many contributions of our dedicated and motivated colleagues including noted bipolar researchers, software engineers, and graphic designers. Most importantly, the scores of bipolar patients who participated in focus groups and tested KIOS in our studies guided the design with their valuable suggestions.

Developing scientifically validated products for more than 35 years.

Biomedical Development Corporation (BDC)

KIOS is a product of Biomedical Development Corporation. BDC was established in 1984 by a research scientist and an attorney-CPA as a for-profit business to combine cutting edge science with business resources, in order to commercialize healthcare products with superior clinical outcomes.

Recognizing that commercialization is a complex undertaking that requires a multitude of scientific and business skills, BDC has developed its technology strategy based on a multidisciplinary approach, integrating teams of distinguished scientists and sophisticated business professionals. BDC fosters an environment of collaboration and sharing among its employees, consultants, university researchers, and government entities.

For more than 35 years, BDC has taken scientific innovations and turned them into products. The BDC headquarters are in Lexington, KY and our manufacturing affiliate is located in San Antonio, TX.

Phyllis Siegel, J.D.

ceo

Gregg Siegel, M.S.

President

© 2017 Biomedical Development Corporation. All rights reserved. Trademarks not belonging to BDC are the property of their respective companies. iPhone and iPad are registered trademarks of Apple Inc.

¹ Research reported in this publication was supported by the National Institute Of Mental Health of the National Institutes of Health under Award Number R42MH091997. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

² This technology was supported in part by an award from the Kentucky Cabinet for Economic Development, Office of Entrepreneurship, under the Grant Agreement KSTC-184-512-15-223 with the Kentucky Science and Technology Corporation